Horsham, UK. 05 October 2018: Seroba Investee, Veryan Medical Ltd, today announced that the Company has received Prema... Read more

1 February¬†2018: Seroba’s investee company, Veryan Medical, has announced that the Company has submitted a Prem... Read more

The MIMICS-2 study is a prospective, multicentre, interventional study designed to evaluate the safety and effectiveness of BioMimics 3... Read more

MIMICS-3D is a prospective, multicentre, observational registry to evaluate the BioMimics 3D Self-Expanding Stent System in the treatme... Read more

TOP